Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization

Journal of General Virology

Volumn 86, Issue 9, 2005, Pages 2535-2542

  Ji, Xin ^a   Olinger, Gene G ^b   Aris, Sheena ^a   Chen, Ying ^a   Gewurz, Henry ^a   Spear, Gregory T ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL SPECIFIC INTERCELLULAR ADHESION MOLECULE 3 GRABBING NON INTEGRIN; MANNOSE BINDING LECTIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; BINDING SITE; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; DENDRITIC CELL; EBOLA VIRUS; HUMAN; HUMAN CELL; MARBURG VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; VESICULAR STOMATITIS VIRUS; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS STRAIN;

BINDING, COMPETITIVE; CELL ADHESION MOLECULES; CELL LINE; COMPLEMENT SYSTEM PROTEINS; EBOLAVIRUS; GENE PRODUCTS, ENV; HUMANS; LECTINS, C-TYPE; MANNOSE-BINDING LECTIN; MARBURGVIRUS; NEUTRALIZATION TESTS; RECEPTORS, CELL SURFACE; VIRAL ENVELOPE PROTEINS;

MARBURG-LIKE VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 23844550737     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81199-0     Document Type: Article

References (66)

1. Alvarez, C. P., Lasala, F., Carrillo, J., Muniz, O., Corbi, A. L. & Delgado, R. (2002). C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 76, 6841-6844.
2. Anders, E. M., Hartley, C. A., Reading, P. C. & Ezekowitz, R. A. (1994). Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. J Gen Virol 75, 615-622.
3. Baribaud, F., Pohlmann, S., Leslie, G., Mortari, F. & Doms, R. W. (2002). Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells. J Virol 76, 9135-9142.
4. Baron, S., Singh, I., Chopra, A., Coppenhaver, D. & Pan, J. (2000). Innate antiviral defenses in body fluids and tissues. Antiviral Res 48, 71-89.
5. 1,2 and inhibits infectivity of Ebola virus. Antiviral Res 58, 47-56.
6. Barrientos, L. G., Lasala, F., Delgado, R., Sanchez, A. & Gronenborn, A. M. (2004a). Flipping the switch from monomeric to dimeric CV-N has little effect on antiviral activity. Structure 12, 1799-1807.
7. Barrientos, L. G., Lasala, F., Otero, J. R., Sanchez, A. & Delgado, R. (2004b). In vitro evaluation of cyanovirin-N antiviral activity, by use of lentiviral vectors pseudotyped with filovirus envelope glycoproteins. J Infect Dis 189, 1440-1443.
8. Bashirova, A. A., Geijtenbeek T. B., van Duijnhoven, G. C. & 10 other authors (2001). A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 193, 671-678.
9. Basler, C. F., Wang, X., Muhlberger, E., Volchkov, V., Paragas, J., Klenk, H. D., Garcia-Sastre, A. & Palese, P. (2000). The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A 97, 12289-12294.
10. Basler, C. F., Mikulasova, A., Martinez-Sobrido, L., Paragas, J., Muhlberger, E., Bray, M., Klenk H. D., Palese, P. & Garcia-Sastre, A. (2003). The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol 77, 7945-7956.
11. Beebe, D. P. & Cooper, N. R. (1981). Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. J Immunol 126, 1562-1568.
12. Biron, C. A. (1998). Role of early cytokines, including alpha and beta interferons (IFN-α/β), in innate and adaptive immune responses to viral infections. Semin Immunol 10, 383-390.
13. Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P. & Salazar-Mather, T. P. (1999). Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17, 189-220.
14. Bolmstedt, A. J., O'Keefe, B. R., Shenoy, S. R., McMahon, J. B. & Boyd, M. R. (2001). Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner. Mol Pharmacol 59, 949-954.
15. Botos, I. & Wlodawer, A. (2003). Cyanovirin-N: a sugar-binding antiviral protein with a new twist. Cell Mol Life Sci 60, 277-287.
16. Bray, M. (2001). The role of the Type I interferon response in the resistance of mice to filovirus infection. J Gen Virol 82, 1365-1373.
17. Chan, S. Y., Speck R. F., Ma, M. C. & Goldsmith, M. A. (2000). Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Virol 74, 4933-4937.
18. Coll, J. M. (1995). The glycoprotein G of rhabdoviruses. Arch Virol 140, 827-851.
19. DePolo, N. J., Reed, J. D., Sheridan, P. L., Townsend, K., Sauter, S. L., Jolly, D. J. & Dubensky, T. W., Jr (2000). VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther 2, 218-222.
20. Esser, M. T., Mori, T., Mondor, I., Sattentau, Q. J., Dey, B., Berger, E. A., Boyd, M. R. & Lifson, J. D. (1999). Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. J Virol 73, 4360-4371.
21. Ezekowitz, R. A. (2003). Role of the mannose-binding lectin in innate immunity. J Infect Dis 187, S335-S339.
22. Ezekowitz, R. A., Kuhlman, M., Groopman, J. E. & Byrn, R. A. (1989). A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 169, 185-196.
23. Feinberg, H., Mitchell, D. A., Drickamer, K. & Weis, W. I. (2001). Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294, 2163-2166.
24. Feldmann, H., Nichol, S. T., Klenk H. D., Peters, C. J. & Sanchez, A. (1994). Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology 199, 469-473.
25. Gadjeva, M., Paludan, S. R., Thiel, S. & 8 other authors (2004). Mannan-binding lectin modulates the response to HSV-2 infection. Clin Exp Immunol 138, 304-311.
26. Geijtenbeek, T. B., Kwon, D. S., Torensma, R. & 9 other authors (2000). DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells [see comments]. Cell 100, 587-597.
27. Geisbert, T. W., Hensley, L. E., Larsen, T. & 7 other authors (2003). Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 163, 2347-2370.
28. Geyer, H., Will, C., Feldmann, H., Klenk, H. D. & Geyer, R. (1992). Carbohydrate structure of Marburg virus glycoprotein. Glycobiology 2, 299-312.
29. Hackett, C. J. (2003). Innate immune activation as a broad-spectrum biodefense strategy: prospects and research challenges. J Allergy Clin Immunol 112, 686-694.
30. Hansen, S. & Holmskov, U. (1998). Structural aspects of collectins and receptors for collectins. Immunobiology 199, 165-189.
31. Hart, M. L., Saifuddin, M., Uemura, K., Bremer, E. G., Hooker, B., Kawasaki, T. & Spear, G. T. (2002). High mannose glycans and sialic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type 1. AIDS Res Hum Retroviruses 18, 1311-1317.
32. Hart, M. L., Saifuddin, M. & Spear, G. T. (2003). Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin. J Gen Virol 84, 353-360.
33. Hartshorn, K. L., Sastry, K., White, M. R., Anders, E. M., Super, M., Ezekowitz, R. A. & Tauber, A. I. (1993). Human mannose-binding protein functions as an opsonin for influenza A viruses. J Clin Invest 91, 1414-1420.
34. Hartshorn, K. L., White, M. R., Shepherd, V., Reid, K., Jensenius, J. C. & Crouch, E. C. (1997). Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am J Physiol 273, L1156-L1166.
35. Haurum, J. S., Thiel, S., Jones, I. M., Fischer, P. B., Laursen, S. B. & Jensenius, J. C. (1993). Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 7, 1307-1313.
36. Hevey, M., Negley, D. & Schmaljohn, A. (2003). Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes. Virology 314, 350-357.
37. Jack D. L., Klein, N. J. & Turner, M. W. (2001). Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 180, 86-99.
38. Ji, X., Gewurz, H. & Spear, G. T. (2005). Mannose binding lectin (MBL) and HIV. Mol Immunol 42, 145-152.
39. Lin, G., Simmons, G., Pohlmann, S. & 8 other authors (2003). Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol 77, 1337-1346.
40. Mahanty, S. & Bray, M. (2004). Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 4, 487-498.
41. Mahanty, S., Gupta, M., Paragas, J., Bray, M., Ahmed, R. & Rollin, P. E. (2003). Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection. Virology 312, 415-424.
42. Marzi, A., Gramberg, T., Simmons, G. & 12 other authors (2004). DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol 78, 12090-12095.
43. Matsushita, M. & Fujita, T. (2001). Ficolins and the lectin complement pathway. Immunol Rev 180, 78-85.
44. Ohtani, K., Suzuki, Y., Eda, S. & 7 other authors (1999). High-level and effective production of human mannan-binding lectin (MBL) in Chinese hamster ovary (CHO) cells. J Immunol Methods 222, 135-144.
45. Petersen, S. V., Thiel, S. & Jensenius, J. C. (2001). The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 38, 133-149.
46. Reading, P. C., Hartley, C. A., Ezekowitz, R. A. & Anders, E. M. (1995). A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells. Biochem Biophys Res Commun 217, 1128-1136.
47. Reed, D. S., Hensley, L. E., Gelsbert, J. B., Jahrling, P. B. & Geisbert, T. W. (2004). Depletion of peripheral blood T lymphocytes and NK cells during the course of Ebola hemorrhagic fever in cynomolgus macaques. Viral Immunol 17, 390-400.
48. Saifuddin, M., Hart, M. L., Gewurz, H., Zhang, Y. & Spear, G. T. (2000). Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J Gen Virol 81, 949-955.
49. Sanchez, A., Trappier, S. G., Mahy, B. W., Peters, C. J. & Nichol, S. T. (1996). The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A 93, 3602-3607.
50. Sanchez, A., Lukwiya, M., Bausch, D., Mahanty, S., Sanchez, A. J., Wagoner, K. D. & Rollin, P. E. (2004). Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol 78, 10370-10377.
51. Simmons, G., Wool-Lewis, R. J., Baribaud, F., Netter, R. C. & Bates, P. (2002). Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Virol 76, 2518-2528.
52. Simmons, G., Reeves, J. D., Grogan, C. C. & 10 other authors (2003). DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305, 115-123.
53. Singh, I. P. & Baron, S. (2000). Innate defences against viraemia. Rev Med Virol 10, 395-403.
54. Spear, G. T., Hart, M., Olinger, G. G., Hashemi, F. B. & Saifuddin, M. (2001). The role of the complement system in virus infections. Curr Top Microbiol Immunol 260, 229-245.
55. Suankratay, C., Zhang, X. H., Zhang, Y., Lint T. F. & Gewurz, H. (1998). Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway. J Immunol 160, 3006-3013.
56. Sullivan, N. J., Peterson, M., Yang, Z. Y., Kong, W. P., Duckers, H., Nabel, E. & Nabel, G. J. (2005). Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway. J Virol 79, 547-553.
57. Takada, A. & Kawaoka, Y. (2001). The pathogenesis of Ebola hemorrhagic fever. Trends Microbiol 9, 506-511.
58. Takada, A. & Kawaoka, Y. (2003). Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol 13, 387-398.
59. Takada, A., Feldmann, H., Ksiazek, T. G. & Kawaoka, Y. (2003). Antibody-dependent enhancement of Ebola virus infection. J Virol 77, 7539-7544.
60. Takada, A., Fujioka, K., Tsuiji, M. & 7 other authors (2004). Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol 78, 2943-2947.
61. Valdimarsson, H., Stefansson, M., Vikingsdottir, T., Arason, G. J., Koch, C., Thiel, S. & Jensenius, J. C. (1998). Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand J Immunol 48, 116-123.
62. Warfield, K. L., Perkins, J. G., Swenson, D. L., Deal, E. M., Bosio, C. M., Aman, M. J., Yokoyama, W. M., Young, H. A. & Bavari, S. (2004). Role of natural killer cells in innate protection against lethal Ebola virus infection. J Exp Med 200, 169-179.
63. Wilson, J. A., Hevey, M., Bakken, R., Guest, S., Bray, M., Schmaljohn, A. L. & Hart, M. K. (2000). Epitopes involved in antibody-mediated protection from Ebola virus. Science 287, 1664-1666.
64. Wu, L., Martin, T. D., Carrington, M. & Kewal Ramani, V. N. (2004). Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology 318, 17-23.
65. Ying, H., Ji, X., Hart, M. L., Gupta, K., Saifuddin, M., Zariffard, M. R. & Spear, G. T. (2004). Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization. AIDS Res Hum Retroviruses 20, 327-335.
66. Zabavichene, N. M. & Chepurnov, A. A. (2004). Dynamics of complement hemolytic activity in experimental Ebola infection. Vopr Virusol 49, 21-25 (in Russian).